Kitov Pharma Ltd (NASDAQ:KTOV) and Cerecor Inc. (NASDAQ:CERC) are two firms in the Biotechnology that compete against each other. Below is a comparison of their risk, institutional ownership, analyst recommendations, profitability, dividends, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Kitov Pharma Ltd 1.00M 22.61 5.20M -0.98 0.00 Cerecor Inc. 15.58M 13.32 41.68M -1.05 0.00 Table 1 shows gross revenue, earnings per share (EPS) and valuation of the two companies. Profitability Table 2 demonstrates the net margins, return on assets and return on equity of Kitov Pharma Ltd and Cerecor Inc. Cerecor Inc. -267.52% -164.9% -63.2% Institutional and Insider Ownership The shares of both Kitov Pharma Ltd and Cerecor Inc. are owned by institutional investors at 8.98% and 49.9% respectively. Competitively, Cerecor Inc. has 4.1% of it’s share owned by insiders. Performance In this table we show the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders. Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD) Kitov Pharma Ltd -4.96% -16.06% -41.62% -59.51% -45.37% -49.56% Cerecor Inc. -4.56% -25.39% -27.02% -20.62% 105.53% 4.69% For the past year Kitov Pharma Ltd has -49.56% weaker performance while Cerecor Inc. has 4.69% stronger performance. Kitov Pharmaceuticals Holdings Ltd., through its subsidiaries, operates as a development stage biopharmaceutical company in Israel. It develops combination drugs for the simultaneous treatment of pain caused by osteoarthritis and hypertension. The companyÂ’s lead drug candidate is KIT-302, a fixed dosage combination product […]
The post Reviewing Kitov Pharma Ltd (KTOV)’s and Cerecor Inc. (NASDAQ:CERC)’s results appeared first on .